Bioequivalence guideline for capecitabine to boost launch of Xeloda generic drugs

Published: 2010-07-06 06:57:00
Updated: 2010-07-06 06:57:00
Korean makers of generic drugs are seeking the Korea Food and Drug Administration approval to sell a copy of Xeloda, whose active ingredient is capecitabine.

To this end, the KFDA has recently announced its new bioequivalence guideline for capecitabine.

The guideline describe the detailed b...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.